SCHEMBL30488012

SCHEMBL30488012

NC(=O)c1sccc1-c1ccon1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BCAT2 O15382 1/20 0.50
ALDH1A1 P00352 5/20 0.38
KDM4E B2RXH2 3/20 0.38
POLB P06746 2/20 0.38
PLA2G10 O15496 1/20 0.35
EDNRA P25101 1/20 0.34
GAA P10253 1/20 0.34
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
MAPT P10636 1/20 0.33
MAPK1 P28482 1/20 0.33
MAPK8 P45983 1/20 0.33
MAPK10 P53779 1/20 0.33
GAPDH P04406 1/20 0.33
HTT P42858 1/20 0.32
CDK8 P49336 1/20 0.32
CDK19 Q9BWU1 1/20 0.32
TSHR P16473 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
NPC1 O15118 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9825634 0.72 KDM4E (0.35) ALDH1A1KDM4EPOLBEDNRAMAPT
SCHEMBL30424151 0.71 BCAT2 (0.58) BCAT2ALDH1A1KDM4EPOLBKMT2A
SCHEMBL29996179 0.71 BCAT2 (0.50) BCAT2ALDH1A1KDM4EPOLBPLA2G10
SCHEMBL1379791 0.71 BCAT2 (0.58) BCAT2ALDH1A1KDM4EPOLBKMT2A
SCHEMBL29543426 0.71 BCAT2 (0.50) BCAT2ALDH1A1KDM4EPOLBPLA2G10
SCHEMBL3346809 0.70 BCAT2 (0.55) BCAT2ALDH1A1KDM4EGAAMAPT
SCHEMBL29894413 0.70 BCAT2 (0.49) BCAT2ALDH1A1KDM4EPOLBPLA2G10
Hydrochloric Acid SCHEMBL29995989 0.70 BCAT2 (0.49) BCAT2ALDH1A1KDM4EPOLBPLA2G10
SCHEMBL27711486 0.70 BCAT2 (0.49) BCAT2ALDH1A1KDM4EPOLBPLA2G10
SCHEMBL16011605 0.68 BCAT2 (0.59) BCAT2ALDH1A1KDM4EPOLBMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4444715-A1 SOLID STATE FORMS OF LOTILANER AND PROCESS FOR PREPARATION THEREOF Teva Pharmaceuticals International GmbH (CH) 2024-10-16 EP disclosed
WO-2023107660-A1 SOLID STATE FORMS OF LOTILANER AND PROCESS FOR PREPARATION THEREOF TEVA PHARMACEUTICALS INTERNATIONAL GMBH (CH) 2023-06-15 WO disclosed